Societal and commercial issues affecting the future of biotechnology in the United States: a survey of researchers' perceptions.
A 1995 survey of 1,257 U.S. recombinant DNA researchers assessed how they view outside factors affecting their work, including public and media attention; regulation; funding; international competition; commercialization of research and university/ industry collaboration; health care reform efforts; and patenting laws and policies. Generally, respondents view public attention as-having had positive effects on biotechnology progress, but they are concerned about the decrease in R&D funding, especially from government; the loss of scientific openness and basic-research quality caused by academic/industrial collaboration; international competition, particularly from Japan and Germany; overly stringent regulations that control R&D processes rather than products; inefficient regulatory agencies focused on irrelevant criteria; and threats to basic biomedical research from the short-term cost focus of managed-care companies.
Rabino
I
I
Department of Biological and Health Sciences, Empire State College, State University of New York, NY 10014-4382, USA.
D001290:Attitude; D001709:Biotechnology / Q000191:economics; D004274:DNA, Recombinant; D006801:Humans; D012106:Research / Q000592:standards; D012108:Research Personnel; D012109:Research Support as Topic; D012941:Social Responsibility; D011795:Surveys and Questionnaires; D014481:United States
D004274:DNA, Recombinant